SPCP20C8.01c Antibody

What is SPCP20C8.01c and why is it significant in fission yeast research?

SPCP20C8.01c is a protein-coding gene in Schizosaccharomyces pombe (fission yeast) that appears to be involved in essential cellular processes. Based on available research, this protein may play a role in cell wall formation and integrity, which is crucial for yeast viability and function. Studies of the closely related protein SPCP20C8.02c have revealed connections to the cell wall structure and potentially glucan synthesis pathways in fission yeast . Understanding this protein is significant for fundamental yeast biology and may provide insights into fungal cell wall assembly mechanisms, which can have implications for antifungal drug development and biotechnology applications.

What applications are SPCP20C8.01c antibodies typically used for?

Antibodies targeting SPCP20C8.01c (and the related SPCP20C8.02c) are primarily used in Western blotting (WB) and ELISA applications . These antibodies allow researchers to detect and quantify the presence of the target protein in various experimental contexts. The antibodies are specifically designed to react with Schizosaccharomyces species , making them valuable tools for studying protein expression, localization, and modifications in fission yeast systems. They can be incorporated into studies examining protein-protein interactions, cellular responses to environmental stressors, and genetic manipulation experiments where verification of protein expression is necessary.

How do I select the appropriate SPCP20C8.01c antibody for my research?

When selecting an SPCP20C8.01c antibody, consider these key factors for optimal experimental outcomes:

• Experimental application: Verify the antibody has been validated for your specific application (WB, ELISA, immunofluorescence, etc.)

• Species reactivity: Ensure the antibody specifically recognizes Schizosaccharomyces proteins if working with fission yeast

• Clonality: Determine whether a polyclonal or monoclonal antibody is more appropriate for your research question

• Validation data: Review available validation data from suppliers, including Western blot images showing specificity

• Published research: Check if the antibody has been successfully used in published studies

• Host species: Select an antibody raised in a species that will minimize cross-reactivity with other antibodies in your experimental system

The currently available SPCP20C8.02c antibodies (which may have cross-reactivity with SPCP20C8.01c) include options from suppliers such as CUSABIO Technology LLC and MyBioSource.com, with the latter specifically using rabbit as the host species .

What controls should I include when working with SPCP20C8.01c antibodies?

Proper experimental controls are essential when working with SPCP20C8.01c antibodies to ensure valid and interpretable results:

• Positive control: Include lysates from wild-type S. pombe strains known to express SPCP20C8.01c

• Negative control: Use samples from knockout strains (if viable) or strains where the protein is known to be absent

• Loading control: Include detection of a housekeeping protein (such as α-tubulin) to normalize expression levels

• Primary antibody control: Run a sample without primary antibody to assess secondary antibody non-specific binding

• Epitope competition: If using a peptide-derived antibody, pre-incubate with the immunizing peptide to confirm specificity

• Isotype control: Include an irrelevant antibody of the same isotype to identify non-specific binding

When performing immunolocalization studies, additional controls such as immunostaining of cells expressing epitope-tagged versions (e.g., HA-tagged constructs) can provide validation of antibody specificity .

How can I optimize Western blot protocols for SPCP20C8.01c detection in fission yeast samples?

Optimizing Western blot protocols for SPCP20C8.01c detection requires specific adaptations for fission yeast samples:

• Cell lysis optimization:

  • Use glass bead disruption in buffer containing protease inhibitors to prevent degradation

  • Include a deglycosylation step if glycosylation interferes with antibody recognition, as seen with related yeast proteins

• Sample preparation:

  • Heat samples at 65°C instead of 95°C to prevent aggregation of membrane proteins

  • If SPCP20C8.01c is membrane-associated, include 1-2% SDS in sample buffer

• Gel selection and transfer:

  • Use 10-12% polyacrylamide gels for optimal resolution

  • For potential glycosylated forms, consider gradient gels (4-15%)

  • Semi-dry transfer at lower voltage for longer periods may improve transfer of membrane proteins

• Antibody incubation:

  • Start with 1:1000 dilution of primary antibody in 5% BSA (rather than milk, which contains glycoproteins)

  • Incubate overnight at 4°C with gentle agitation

  • Increase wash steps to reduce background (5 x 5 minutes with TBST)

• Signal development:

  • Use enhanced chemiluminescence detection systems for highest sensitivity

  • Consider signal enhancers specifically designed for yeast protein detection

• Troubleshooting specific issues:

  • If detecting multiple bands, perform proteinase K protection assays to verify specificity

  • For weak signals, incorporate a signal enhancement step or increase antibody concentration

What approaches can be used to study SPCP20C8.01c post-translational modifications?

Studying post-translational modifications (PTMs) of SPCP20C8.01c requires specialized techniques:

• Glycosylation analysis:

  • Treat samples with endoglycosidase H (EndoH) to remove N-linked glycans and observe mobility shifts on Western blots

  • For O-mannosylation analysis, compare protein mobility in wild-type versus O-mannosyl transferase mutant backgrounds

  • Use PAS-Silver staining to specifically detect glycoproteins in purified samples

• Phosphorylation analysis:

  • Employ Phos-tag acrylamide gels to separate phosphorylated from non-phosphorylated forms

  • Use phosphatase treatments to confirm phosphorylation status

  • Consider mass spectrometry for precise phosphorylation site mapping

• Membrane association and topology:

  • Perform proteinase K protection assays to determine protein orientation in membranes

  • Use cell wall biotinylation techniques to assess surface exposure

  • Employ ratiometric measurements with fluorescent protein fusions to study localization dynamics

• Other modifications:

  • Analyze ubiquitination status through immunoprecipitation followed by ubiquitin-specific Western blotting

  • Investigate potential GPI anchoring through PI-PLC treatment sensitivity

Research on related proteins in fission yeast suggests that SPCP20C8.01c may undergo O-mannosylation and potentially other PTMs that affect its function in cell wall integrity pathways .

How can I design experiments to investigate SPCP20C8.01c interactions with other cell wall proteins?

Investigating SPCP20C8.01c interactions with other cell wall proteins requires comprehensive experimental approaches:

• Co-immunoprecipitation (Co-IP) strategies:

  • Generate epitope-tagged versions of SPCP20C8.01c (HA or FLAG tags) for immunoprecipitation

  • Use crosslinking approaches (formaldehyde or DSP) to capture transient interactions

  • Perform reciprocal Co-IPs with antibodies against suspected interaction partners

  • Include detergent optimization to maintain membrane protein interactions

• Proximity labeling techniques:

  • Create BioID or TurboID fusions to SPCP20C8.01c for in vivo proximity labeling

  • Analyze biotinylated proteins by mass spectrometry to identify proximal proteins

  • Validate interactions with targeted Co-IP or microscopy approaches

• Genetic interaction screens:

  • Perform synthetic genetic array analysis with SPCP20C8.01c mutants

  • Look for genetic suppressors or enhancers that may indicate functional relationships

  • Create conditional mutants if SPCP20C8.01c is essential

• Localization studies:

  • Use fluorescently tagged proteins to assess co-localization patterns

  • Employ super-resolution microscopy for detailed spatial relationships

  • Analyze protein distribution in different cell cycle stages and during septum formation

• Biochemical fractionation:

  • Isolate cell wall fractions and analyze protein composition

  • Perform sequential extractions to determine strength of cell wall associations

  • Use chemical crosslinking of intact cells followed by identification of crosslinked partners

Considering SPCP20C8.01c's potential involvement in cell wall integrity, focus on interactions with β-1,6-glucan synthesis machinery components and other structural proteins .

How can I establish a conditional expression system for studying essential proteins like SPCP20C8.01c?

If SPCP20C8.01c is essential (as suggested by research on related proteins ), establishing conditional expression systems is crucial:

• Promoter replacement strategies:

  • Replace the native promoter with the nmt1 promoter series (high, medium, or low strength) for thiamine-repressible expression

  • Use the urg1 promoter for uracil-inducible expression with rapid on/off kinetics

  • Implement the tetO promoter system for doxycycline-controlled expression

• Degron-based approaches:

  • Fuse an auxin-inducible degron (AID) tag to rapidly deplete the protein upon auxin addition

  • Use temperature-sensitive degron tags for heat-inducible protein degradation

  • Apply the SMASh tag system for small molecule-induced protein stabilization

• Genetic approaches:

  • Create heterozygous diploid deletion strains to study haploinsufficiency effects

  • Generate temperature-sensitive alleles through error-prone PCR and screening

  • Implement a genomic promoter-swap strategy that maintains native expression levels during normal growth

• Validation methods:

  • Confirm conditional expression/depletion using the SPCP20C8.01c antibody via Western blotting

  • Monitor phenotypic changes at different expression levels

  • Use microscopy to track morphological changes upon protein depletion

  • Employ cell wall integrity assays to correlate protein levels with functional outcomes

• Data analysis considerations:

  • Establish dose-response relationships between inducer/repressor and protein levels

  • Determine the minimal protein level required for viability

  • Create time-course analyses of phenotypic changes following protein depletion

What approaches can be used to study SPCP20C8.01c function in septum formation and cell division?

To investigate SPCP20C8.01c's potential role in septum formation and cell division:

• Live cell imaging techniques:

  • Create fluorescently tagged versions of SPCP20C8.01c to monitor localization during cell cycle

  • Use time-lapse microscopy to track protein dynamics during septum formation

  • Employ dual-color imaging with septum markers (e.g., Bgs1) to assess co-localization

• Septum composition analysis:

  • Isolate septa at different stages of formation using cell wall digestion techniques

  • Analyze β-1,6-glucan content in septa from wild-type and SPCP20C8.01c-depleted cells

  • Use transmission electron microscopy to examine septum ultrastructure

• Cell cycle synchronization:

  • Synchronize cells using centrifugal elutriation or cell cycle mutants

  • Analyze SPCP20C8.01c levels and localization at specific cell cycle points

  • Correlate with septum assembly markers to establish temporal relationships

• Genetic interaction studies:

  • Screen for genetic interactions with known septum formation genes

  • Create double mutants with septum separation enzymes to assess functional relationships

  • Analyze phenotypes of hyperactive or inactive SPCP20C8.01c mutants

• Biochemical approaches:

  • Perform immunoprecipitation during different stages of septum formation

  • Analyze post-translational modifications specific to cell division phases

  • Use in vitro assays to test enzymatic activities or protein interactions

This multi-faceted approach will help determine if SPCP20C8.01c functions directly in septum formation, as suggested by research on related proteins in fission yeast .

How can I develop a quantitative assay to measure SPCP20C8.01c-dependent effects on cell wall integrity?

Developing quantitative assays for measuring SPCP20C8.01c-dependent effects on cell wall integrity requires:

• Growth-based quantitative assays:

  • Measure growth rates in liquid culture with cell wall-challenging agents (calcofluor white, congo red)

  • Perform serial dilution spot assays on plates containing various concentrations of cell wall stressors

  • Use automated growth curve analysis with plate readers to generate quantitative stress response data

• Microscopy-based quantification:

  • Develop high-throughput imaging workflows to analyze cell morphology changes

  • Quantify septation defects using automated image analysis

  • Measure cell lysis rates under osmotic stress conditions

• Biochemical composition analysis:

  • Quantify β-1,6-glucan content using specific antibodies or enzymatic digestion methods

  • Measure alkali-soluble vs. alkali-insoluble glucan fractions

  • Analyze cell wall protein content in wild-type vs. SPCP20C8.01c-depleted cells

• Mechanical property measurements:

  • Employ atomic force microscopy to measure cell wall elasticity

  • Use microfluidic devices to assess resistance to mechanical stress

  • Develop quantitative cell lysis assays based on enzyme release

• Competition binding assays:

  • Adapt novel antibody competition binding assays as described for other systems

  • Develop multiplex assays to measure epitope-specific concentrations of SPCP20C8.01c and interacting partners

  • Correlate antibody equivalency measurements with functional outcomes

These approaches provide complementary data sets that together create a comprehensive quantitative assessment of SPCP20C8.01c's role in cell wall integrity.

What strategies can I use to overcome common challenges in immunoprecipitation of cell wall-associated proteins like SPCP20C8.01c?

Immunoprecipitation of cell wall-associated proteins presents unique challenges that require specialized approaches:

• Optimized lysis conditions:

  • Use a combination of mechanical disruption (glass beads) and enzymatic treatments

  • Test multiple detergents (CHAPS, digitonin, DDM) at varying concentrations

  • Include cell wall digesting enzymes (glucanases) to release wall-bound proteins

  • Maintain low temperature throughout to prevent degradation

• Antibody coupling strategies:

  • Directly couple purified antibodies to magnetic beads to eliminate co-elution of antibody chains

  • Use chemical crosslinking to prevent antibody leaching during elution

  • Consider orientation-specific coupling to maximize epitope accessibility

• Pre-clearing procedures:

  • Implement extensive pre-clearing with unconjugated beads to reduce non-specific binding

  • Include competitive blocking agents specific to yeast components

  • Use species-matched IgG pre-clearing for highest specificity

• Elution optimization:

  • Test mild elution conditions (competitive peptides) to maintain protein interactions

  • For studying strong interactions, employ on-bead digestion for mass spectrometry

  • Use sequential elution strategies to discriminate between weak and strong interactions

• Verification approaches:

  • Perform reverse immunoprecipitation with antibodies against interaction partners

  • Include spike-in controls of known concentrations for quantification

  • Use advanced mass spectrometry techniques for unbiased interaction identification

When working specifically with SPCP20C8.01c and related proteins, consider using specialized approaches like cell wall biotinylation prior to lysis, which can help track surface-exposed portions of the protein .

How can I differentiate between closely related proteins (like SPCP20C8.01c and SPCP20C8.02c) in my experiments?

Differentiating between closely related proteins requires specialized approaches:

• Antibody-based strategies:

  • Generate peptide antibodies targeting unique regions that differ between SPCP20C8.01c and SPCP20C8.02c

  • Perform peptide competition assays to confirm specificity

  • Use epitope tagging at endogenous loci to create distinguishable versions

  • Implement antibody validation in knockout or depletion strains

• Mass spectrometry approaches:

  • Identify unique peptides that differentiate between the proteins

  • Develop targeted MS assays (MRM/PRM) focusing on distinguishing peptides

  • Use isotopically labeled reference peptides for absolute quantification

• Genetic approaches:

  • Create strains with individual deletions or depletions to establish protein-specific phenotypes

  • Implement strain-specific tags for unambiguous identification

  • Use CRISPR-Cas9 to introduce specific mutations that affect one protein but not the other

• Expression pattern analysis:

  • Study differential expression under various conditions using RT-qPCR with gene-specific primers

  • Analyze localization patterns that may differ between the proteins

  • Investigate condition-specific regulation that may uniquely affect one protein

• Functional assessment:

  • Design assays that can detect functional differences between the proteins

  • Perform complementation studies to determine functional redundancy

  • Develop in vitro activity assays that can differentiate based on enzymatic or binding properties

This multi-layered approach ensures accurate identification and characterization of the specific protein of interest.

What are the best practices for validating SPCP20C8.01c antibody specificity in fission yeast systems?

Comprehensive validation of SPCP20C8.01c antibody specificity involves multiple complementary approaches:

• Genetic validation:

  • Test antibody reactivity in wild-type versus knockout strains (if viable)

  • Use conditional depletion systems to show signal reduction correlating with protein depletion

  • Analyze overexpression strains to confirm signal increase

• Molecular weight verification:

  • Compare observed band size with predicted molecular weight

  • Account for post-translational modifications that affect migration

  • Use epitope-tagged versions to confirm identity via tag-specific antibodies

• Peptide competition:

  • Pre-incubate antibody with immunizing peptide to demonstrate specific signal blocking

  • Use dose-response curves with competing peptide to quantify specificity

  • Test related peptides to evaluate cross-reactivity potential

• Cross-reactivity assessment:

  • Test antibody against related species and paralogs

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

  • Evaluate signal in cells expressing related proteins from other yeast species

• Application-specific validation:

  • For each application (WB, IF, IP), perform separate validation experiments

  • Document specificity across different sample preparation methods

  • Validate under the exact experimental conditions to be used in research

• Advanced validation approaches:

  • Implement epitope mapping to precisely define the antibody binding site

  • Use surface plasmon resonance to measure binding kinetics and specificity

  • Perform multiplexed antibody validation using proteome microarrays

Proper validation ensures experimental reproducibility and reliable research outcomes when working with SPCP20C8.01c antibodies.

How can I develop a competitive binding assay to study SPCP20C8.01c interactions with cell wall components?

Developing a competitive binding assay for SPCP20C8.01c interactions with cell wall components requires:

• Assay design considerations:

  • Adapt multiplex competition assays similar to those used for CSP-specific antibodies

  • Establish a panel of well-characterized monoclonal antibodies targeting different epitopes

  • Develop a method to quantify equivalency with functionally-active monoclonal antibodies

• Substrate preparation:

  • Isolate and purify cell wall components (β-1,6-glucan, mannoproteins)

  • Immobilize purified components on appropriate surfaces (beads, plates)

  • Label SPCP20C8.01c protein with detectable tags (fluorescent, enzymatic)

• Assay optimization parameters:

  • Determine optimal buffer conditions that maintain protein-carbohydrate interactions

  • Establish protein:substrate ratios for ideal signal-to-noise ratios

  • Develop positive and negative controls for assay validation

• Quantification methods:

  • Implement dose-response measurements to calculate binding affinities

  • Use competition with unlabeled components to assess specificity

  • Develop high-throughput readout systems (fluorescence polarization, FRET)

• Validation approaches:

  • Compare in vitro binding results with in vivo functional assays

  • Test binding of mutant proteins to identify critical interaction residues

  • Correlate binding measurements with cell wall integrity phenotypes

• Advanced applications:

  • Screen for small molecules that disrupt or enhance binding

  • Investigate environmental factors (pH, temperature) affecting interactions

  • Map the exact binding interface using mutational analysis

This approach would generate both qualitative and quantitative data on SPCP20C8.01c interactions with cell wall components, providing insights into its functional role.

How can I integrate proteomics and genomics approaches to study SPCP20C8.01c function in fission yeast?

Integrating proteomics and genomics for SPCP20C8.01c functional studies requires:

• Comprehensive experimental design:

  • Create conditional SPCP20C8.01c expression/depletion systems

  • Design time-course experiments capturing early and late effects

  • Include relevant genetic backgrounds (cell wall mutants, stress response mutants)

• Multi-omics data collection:

  • Perform RNA-seq to identify transcriptional changes upon SPCP20C8.01c depletion/overexpression

  • Use quantitative proteomics to analyze protein abundance changes

  • Implement phosphoproteomics to identify signaling pathways affected

  • Analyze the cell wall glycome using mass spectrometry-based methods

• Data integration strategies:

  • Apply network analysis to identify functional modules affected

  • Use pathway enrichment to highlight biological processes impacted

  • Implement time-resolved analysis to distinguish primary from secondary effects

  • Correlate transcriptional changes with proteome alterations

• Validation experiments:

  • Select key genes/proteins for targeted functional studies

  • Create reporter systems for pathway activation

  • Validate predictions using genetic approaches (deletions, overexpression)

• Systems-level interpretation:

  • Place SPCP20C8.01c in the context of cell wall integrity pathways

  • Identify potential compensatory mechanisms activated upon protein depletion

  • Map the temporal sequence of cellular responses

• Specialized analyses:

  • Perform microarray hybridization and data analysis specific to cell wall genes

  • Use ratiometric measurements with fluorescent protein fusions to study localization changes

  • Implement mass spectrometry for precise characterization of post-translational modifications

This integrated approach provides a comprehensive understanding of SPCP20C8.01c's role within the cellular network.

What techniques can I use to study the structure-function relationship of SPCP20C8.01c in the context of cell wall assembly?

Investigating structure-function relationships of SPCP20C8.01c requires:

• Protein domain analysis and mutagenesis:

  • Perform in silico analysis to identify conserved domains and potential functional motifs

  • Create targeted mutations of key residues predicted to be important for function

  • Generate domain deletion variants to determine the role of specific protein regions

  • Test mutant constructs for their ability to complement knockout phenotypes

• Structural biology approaches:

  • Express and purify protein domains for crystallization attempts

  • Use cryo-electron microscopy for larger assemblies or membrane-associated forms

  • Implement NMR spectroscopy for dynamic regions and interaction studies

  • Apply hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

• Localization and dynamics studies:

  • Create fluorescent protein fusions to track protein localization during cell wall synthesis

  • Use FRAP (Fluorescence Recovery After Photobleaching) to measure protein mobility

  • Implement super-resolution microscopy to precisely map protein locations relative to cell wall structures

  • Employ proximity labeling to identify proteins in the immediate vicinity

• Functional correlation:

  • Develop quantitative assays to measure functionality of mutant proteins

  • Correlate structural features with specific aspects of cell wall assembly

  • Perform rescue experiments with chimeric proteins to identify essential domains

• Evolutionary analysis:

  • Compare SPCP20C8.01c with homologs from related species

  • Identify conserved regions that may represent functionally critical domains

  • Perform phylogenetic analysis to understand evolutionary constraints

These approaches will connect structural features of SPCP20C8.01c to its functional role in cell wall assembly, potentially revealing mechanistic insights into its activity and regulation.